X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule i…
Biotechnology
US, Boston [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
X4 Pharmaceuticals, Inc. has no acquisition track records yet.
M&A Deals · History
X4 Pharmaceuticals, Inc. has no acquisition track records yet.